Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Myeloma Bispecific Antibody Research

Laura Rosinol

MD, PhD

🏢Hospital Clinic de Barcelona🌐Spain

Senior Hematologist

42
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Laura Rosinol is an experienced myeloma clinician-researcher who has contributed to the GEM/PETHEMA group trials evaluating novel agents including bispecific antibodies. Her research on consolidation and maintenance strategies has informed treatment duration decisions. She is investigating the role of bispecific antibodies in post-transplant maintenance settings.

Share:

🧪Research Fields 研究领域

Myeloma consolidation therapy
Bispecific maintenance
GEM clinical trials
High-risk myeloma
Post-transplant immunotherapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Laura Rosinol 的研究动态

Follow Laura Rosinol's research updates

留下邮箱,当我们发布与 Laura Rosinol(Hospital Clinic de Barcelona)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment